SP-20104 (Sarfez Pharmaceuticals)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSP-20104 (Sarfez Pharmaceuticals)
Drug Alias NameSP-20104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRenin inhibitors
TargetsRenin
Therapy Area/IndicationsGlomerulosclerosis, Focal Segmental
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator Companies1 A Pharma Gmbh
China Registration ClassN/A

Develop Information

Active Companies1 A Pharma Gmbh
Inactive CompaniesN/A
Active IndicationsGlomerulosclerosis, Focal Segmental
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A